Research Article

Histopathological Diagnostic Discrepancies in Soft Tissue Tumours Referred to a Specialist Centre: Reassessment in the Era of Ancillary Molecular Diagnosis

Table 3

Summary of cases showing major discrepancy.

Referral diagnosisFinal Diagnosis

BenignMalignant (Including locally aggressive, although non-metastasising neoplasms)

AngiomyxomaFibromatosis1
Nerve sheath tumourFibromatosis1
Granular cell tumour (benign)Granular cell tumour (malignant)4
(1 patient)
HaemangiopericytomaDDL1
LeiomyomaLeiomyosarcoma2
Reactive tissueLeiomyosarcoma1

Malignant (Including locally aggressive although non-metastasising neoplasms)Benign

FibromatosisScar1
FibromatosisNuchal-type fibroma1
ALTLipoma2
MPNSTAtypical neurofibroma1
LeiomyosarcomaBFH1
DFSPBFH1
Metastatic renal carcinomaClear cell BFH1
AngiosarcomaHaemangioma1
GISTFibrous tissue only1
LeiomyosarcomaSchwannoma1
IMTWegener’s granulomatosis1

MalignantMalignant

STUMPLeiomyosarcoma (grade 2)2
ESSLeiomyosarcoma1
ESSOsteosarcoma1
GISTSpindle cell sarcoma1
GISTSpindle RMS1
LeiomyosarcomaMPNST1
LGFMSFibromatosis1
LGFMSDDL1
Synovial sarcomaMalignant neoplasm1

BenignBenign

SchwannomaBenign naevus1

MesenchymalNon-mesenchymal

UPSCarcinosarcoma4
Synovial sarcomaCarcinosarcoma1
ChondrosarcomaCarcinosarcoma1
LeiomyosarcomaCarcinosarcoma1
SarcomaSeminoma1
MPNSTMelanoma2
Non-mesenchymal Mesenchymal

CarcinomaPleomorphic RMS1
CarcinomaSpindle cell sarcoma1
LymphomaSFT1

Non-mesenchymalNon-mesenchymal

Undifferentiated carcinomaProstatic carcinoma1

GradeGrade

GIST grade 2/3GIST 12
Leiomyosarcoma 2/3Leiomyosarcoma 12
Leiomyosarcoma 1Leiomyosarcoma 21
Myxofibrosarcoma 2Myxofibrosarcoma 11
WDLDDL grade 21
High grade sarcomaESS1

Abbreviations: ALT atypical lipomatous tumour; BFH benign fibrous histiocytoma; DFSP dermatofibrosarcoma protuberans; DDL dedifferentiated liposarcoma; ESS endometrial stromal sarcoma; GIST gastrointestinal stromal tumour; IMT inflammatory myofibroblastic tumour; LGFMS low grade fibromyxoid sarcoma; MPNST malignant peripheral nerve sheath tumour; RMS rhabdomyosarcoma; SFT solitary fibrous tumour; STUMP smooth muscle tumour of uncertain malignant potential; UPS undifferentiated pleomorphic sarcoma; WDL well differentiated liposarcoma.